The hemorrhage control system market is projected to grow from USD 4.5 billion in 2025 to USD 6.0 billion by 2035, at a CAGR of 3.0%. Hemostatic Devices will dominate with a 54.2% market share, while cardiovascular surgery will lead the application segment with a 47.6% share.